 | • レポートコード：QYR9NV05962 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、異常ヘモグロビン症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、サラセミア療法、鎌状赤血球症（SCD）療法、その他療法に、用途別には、アルファサラセミア、ベータサラセミア、鎌状赤血球症、Hbバリアント病にセグメント区分し、異常ヘモグロビン症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・異常ヘモグロビン症薬の世界市場概要 ・異常ヘモグロビン症薬の製造コスト構成分析 ・異常ヘモグロビン症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・異常ヘモグロビン症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・異常ヘモグロビン症薬のセグメント分析（種類別） （サラセミア療法、鎌状赤血球症（SCD）療法、その他療法） ・異常ヘモグロビン症薬のセグメント分析（用途別） （アルファサラセミア、ベータサラセミア、鎌状赤血球症、Hbバリアント病） ・異常ヘモグロビン症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Gamida Cell、Alnylam Pharmaceuticals、Biogen Idec、Sangamo BioSciences Inc.、Genetix Pharmaceuticals/Bluebird Bio、Global Blood Therapeutics Inc.、Pfizer Inc.、Mast Therapeutics、Emmaus Life Sciences, Inc.、Prolong Pharmaceuticals、Celgene Corporation、HemaQuest Pharmaceuticals、） ・異常ヘモグロビン症薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Hemoglobinopathies Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hemoglobinopathies Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemoglobinopathies Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hemoglobinopathies Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hemoglobinopathies Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Gamida Cell
Alnylam Pharmaceuticals
Biogen Idec
Sangamo BioSciences Inc.
Genetix Pharmaceuticals/Bluebird Bio
Global Blood Therapeutics Inc.
Pfizer Inc.
Mast Therapeutics
Emmaus Life Sciences, Inc.
Prolong Pharmaceuticals
Celgene Corporation
HemaQuest Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Thalassemia Therapy
Sickle Cell Disease(SCD) Therapy
Other Therapy
Segment by Application
Alpha Thalassemia
Beta thalassemia
Sickle Cell Disease
Hb Variants Diseases
Table of Contents
Executive Summary
1 Industry Overview of Hemoglobinopathies Drugs
1.1 Definition of Hemoglobinopathies Drugs
1.2 Hemoglobinopathies Drugs Segment by Type
1.2.1 Global Hemoglobinopathies Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Thalassemia Therapy
1.2.3 Sickle Cell Disease(SCD) Therapy
1.2.4 Other Therapy
1.3 Hemoglobinopathies Drugs Segment by Applications
1.3.1 Global Hemoglobinopathies Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Alpha Thalassemia
1.3.3 Beta thalassemia
1.3.4 Sickle Cell Disease
1.3.5 Hb Variants Diseases
1.4 Global Hemoglobinopathies Drugs Overall Market
1.4.1 Global Hemoglobinopathies Drugs Revenue (2014-2025)
1.4.2 Global Hemoglobinopathies Drugs Production (2014-2025)
1.4.3 North America Hemoglobinopathies Drugs Status and Prospect (2014-2025)
1.4.4 Europe Hemoglobinopathies Drugs Status and Prospect (2014-2025)
1.4.5 China Hemoglobinopathies Drugs Status and Prospect (2014-2025)
1.4.6 Japan Hemoglobinopathies Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hemoglobinopathies Drugs Status and Prospect (2014-2025)
1.4.8 India Hemoglobinopathies Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hemoglobinopathies Drugs
2.3 Manufacturing Process Analysis of Hemoglobinopathies Drugs
2.4 Industry Chain Structure of Hemoglobinopathies Drugs
3 Development and Manufacturing Plants Analysis of Hemoglobinopathies Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Hemoglobinopathies Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hemoglobinopathies Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Hemoglobinopathies Drugs Production and Capacity Analysis
4.2 Hemoglobinopathies Drugs Revenue Analysis
4.3 Hemoglobinopathies Drugs Price Analysis
4.4 Market Concentration Degree
5 Hemoglobinopathies Drugs Regional Market Analysis
5.1 Hemoglobinopathies Drugs Production by Regions
5.1.1 Global Hemoglobinopathies Drugs Production by Regions
5.1.2 Global Hemoglobinopathies Drugs Revenue by Regions
5.2 Hemoglobinopathies Drugs Consumption by Regions
5.3 North America Hemoglobinopathies Drugs Market Analysis
5.3.1 North America Hemoglobinopathies Drugs Production
5.3.2 North America Hemoglobinopathies Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hemoglobinopathies Drugs Import and Export
5.4 Europe Hemoglobinopathies Drugs Market Analysis
5.4.1 Europe Hemoglobinopathies Drugs Production
5.4.2 Europe Hemoglobinopathies Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hemoglobinopathies Drugs Import and Export
5.5 China Hemoglobinopathies Drugs Market Analysis
5.5.1 China Hemoglobinopathies Drugs Production
5.5.2 China Hemoglobinopathies Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hemoglobinopathies Drugs Import and Export
5.6 Japan Hemoglobinopathies Drugs Market Analysis
5.6.1 Japan Hemoglobinopathies Drugs Production
5.6.2 Japan Hemoglobinopathies Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hemoglobinopathies Drugs Import and Export
5.7 Southeast Asia Hemoglobinopathies Drugs Market Analysis
5.7.1 Southeast Asia Hemoglobinopathies Drugs Production
5.7.2 Southeast Asia Hemoglobinopathies Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hemoglobinopathies Drugs Import and Export
5.8 India Hemoglobinopathies Drugs Market Analysis
5.8.1 India Hemoglobinopathies Drugs Production
5.8.2 India Hemoglobinopathies Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hemoglobinopathies Drugs Import and Export
6 Hemoglobinopathies Drugs Segment Market Analysis (by Type)
6.1 Global Hemoglobinopathies Drugs Production by Type
6.2 Global Hemoglobinopathies Drugs Revenue by Type
6.3 Hemoglobinopathies Drugs Price by Type
7 Hemoglobinopathies Drugs Segment Market Analysis (by Application)
7.1 Global Hemoglobinopathies Drugs Consumption by Application
7.2 Global Hemoglobinopathies Drugs Consumption Market Share by Application (2014-2019)
8 Hemoglobinopathies Drugs Major Manufacturers Analysis
8.1 Gamida Cell
8.1.1 Gamida Cell Hemoglobinopathies Drugs Production Sites and Area Served
8.1.2 Gamida Cell Product Introduction, Application and Specification
8.1.3 Gamida Cell Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Alnylam Pharmaceuticals
8.2.1 Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
8.2.2 Alnylam Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Biogen Idec
8.3.1 Biogen Idec Hemoglobinopathies Drugs Production Sites and Area Served
8.3.2 Biogen Idec Product Introduction, Application and Specification
8.3.3 Biogen Idec Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sangamo BioSciences Inc.
8.4.1 Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production Sites and Area Served
8.4.2 Sangamo BioSciences Inc. Product Introduction, Application and Specification
8.4.3 Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Genetix Pharmaceuticals/Bluebird Bio
8.5.1 Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production Sites and Area Served
8.5.2 Genetix Pharmaceuticals/Bluebird Bio Product Introduction, Application and Specification
8.5.3 Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Global Blood Therapeutics Inc.
8.6.1 Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production Sites and Area Served
8.6.2 Global Blood Therapeutics Inc. Product Introduction, Application and Specification
8.6.3 Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pfizer Inc.
8.7.1 Pfizer Inc. Hemoglobinopathies Drugs Production Sites and Area Served
8.7.2 Pfizer Inc. Product Introduction, Application and Specification
8.7.3 Pfizer Inc. Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Mast Therapeutics
8.8.1 Mast Therapeutics Hemoglobinopathies Drugs Production Sites and Area Served
8.8.2 Mast Therapeutics Product Introduction, Application and Specification
8.8.3 Mast Therapeutics Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Emmaus Life Sciences, Inc.
8.9.1 Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production Sites and Area Served
8.9.2 Emmaus Life Sciences, Inc. Product Introduction, Application and Specification
8.9.3 Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Prolong Pharmaceuticals
8.10.1 Prolong Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
8.10.2 Prolong Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Prolong Pharmaceuticals Hemoglobinopathies Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Celgene Corporation
8.12 HemaQuest Pharmaceuticals
9 Development Trend of Analysis of Hemoglobinopathies Drugs Market
9.1 Global Hemoglobinopathies Drugs Market Trend Analysis
9.1.1 Global Hemoglobinopathies Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Hemoglobinopathies Drugs Regional Market Trend
9.2.1 North America Hemoglobinopathies Drugs Forecast 2019-2025
9.2.2 Europe Hemoglobinopathies Drugs Forecast 2019-2025
9.2.3 China Hemoglobinopathies Drugs Forecast 2019-2025
9.2.4 Japan Hemoglobinopathies Drugs Forecast 2019-2025
9.2.5 Southeast Asia Hemoglobinopathies Drugs Forecast 2019-2025
9.2.6 India Hemoglobinopathies Drugs Forecast 2019-2025
9.3 Hemoglobinopathies Drugs Market Trend (Product Type)
9.4 Hemoglobinopathies Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hemoglobinopathies Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Hemoglobinopathies Drugs
Table Global Hemoglobinopathies Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Hemoglobinopathies Drugs Production Market Share by Types in 2018
Figure Thalassemia Therapy Product Picture
Figure Sickle Cell Disease(SCD) Therapy Product Picture
Figure Other Therapy Product Picture
Table Global Hemoglobinopathies Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Hemoglobinopathies Drugs Consumption Market Share by Applications in 2018
Figure Alpha Thalassemia
Figure Beta thalassemia
Figure Sickle Cell Disease
Figure Hb Variants Diseases
Figure Global Hemoglobinopathies Drugs Revenue (Million USD) (2014-2025)
Figure Global Hemoglobinopathies Drugs Production (K Pcs) (2014-2025)
Figure North America Hemoglobinopathies Drugs Market Size (Million USD) (2014-2025)
Figure Europe Hemoglobinopathies Drugs Market Size (Million USD) (2014-2025)
Figure China Hemoglobinopathies Drugs Market Size (Million USD) (2014-2025)
Figure Japan Hemoglobinopathies Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hemoglobinopathies Drugs Market Size (Million USD) (2014-2025)
Figure India Hemoglobinopathies Drugs Market Size (Million USD) (2014-2025)
Table Hemoglobinopathies Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hemoglobinopathies Drugs in 2018
Figure Manufacturing Process Analysis of Hemoglobinopathies Drugs
Figure Industry Chain Structure of Hemoglobinopathies Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hemoglobinopathies Drugs Manufacturing Plants Distribution
Table Hemoglobinopathies Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hemoglobinopathies Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Hemoglobinopathies Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Hemoglobinopathies Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Hemoglobinopathies Drugs Production Share by Manufacturers in 2018
Table Hemoglobinopathies Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hemoglobinopathies Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hemoglobinopathies Drugs Revenue Share by Manufacturers in 2018
Table Hemoglobinopathies Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hemoglobinopathies Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Hemoglobinopathies Drugs Production Market Share by Regions 2014-2019
Figure Global Hemoglobinopathies Drugs Production Market Share by Regions in 2018
Table Global Hemoglobinopathies Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Hemoglobinopathies Drugs Revenue Market Share by Regions 2014-2019
Figure Global Hemoglobinopathies Drugs Revenue Market Share by Regions in 2018
Table Global Hemoglobinopathies Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Hemoglobinopathies Drugs Consumption Market Share by Regions 2014-2019
Figure North America Hemoglobinopathies Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Hemoglobinopathies Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hemoglobinopathies Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Hemoglobinopathies Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Hemoglobinopathies Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hemoglobinopathies Drugs Production, Consumption Import and Export (K Pcs)
Figure China Hemoglobinopathies Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Hemoglobinopathies Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Hemoglobinopathies Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Hemoglobinopathies Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Hemoglobinopathies Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hemoglobinopathies Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Hemoglobinopathies Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Hemoglobinopathies Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hemoglobinopathies Drugs Production, Consumption Import and Export (K Pcs)
Figure India Hemoglobinopathies Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Hemoglobinopathies Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Hemoglobinopathies Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Hemoglobinopathies Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hemoglobinopathies Drugs Market Share by Application (2014-2019)
Table Gamida Cell Hemoglobinopathies Drugs Production Sites and Area Served
Table Gamida Cell Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Gamida Cell Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Gamida Cell Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Gamida Cell Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Gamida Cell Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Gamida Cell Hemoglobinopathies Drugs Main Business and Markets Served
Table Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
Table Alnylam Pharmaceuticals Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Alnylam Pharmaceuticals Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Alnylam Pharmaceuticals Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Alnylam Pharmaceuticals Hemoglobinopathies Drugs Main Business and Markets Served
Table Biogen Idec Hemoglobinopathies Drugs Production Sites and Area Served
Table Biogen Idec Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Biogen Idec Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen Idec Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Biogen Idec Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Biogen Idec Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Biogen Idec Hemoglobinopathies Drugs Main Business and Markets Served
Table Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production Sites and Area Served
Table Sangamo BioSciences Inc. Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Sangamo BioSciences Inc. Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Sangamo BioSciences Inc. Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Sangamo BioSciences Inc. Hemoglobinopathies Drugs Main Business and Markets Served
Table Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production Sites and Area Served
Table Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Main Business and Markets Served
Table Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production Sites and Area Served
Table Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Main Business and Markets Served
Table Pfizer Inc. Hemoglobinopathies Drugs Production Sites and Area Served
Table Pfizer Inc. Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Pfizer Inc. Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Inc. Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Pfizer Inc. Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Pfizer Inc. Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Pfizer Inc. Hemoglobinopathies Drugs Main Business and Markets Served
Table Mast Therapeutics Hemoglobinopathies Drugs Production Sites and Area Served
Table Mast Therapeutics Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Mast Therapeutics Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mast Therapeutics Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Mast Therapeutics Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Mast Therapeutics Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Mast Therapeutics Hemoglobinopathies Drugs Main Business and Markets Served
Table Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production Sites and Area Served
Table Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Main Business and Markets Served
Table Prolong Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
Table Prolong Pharmaceuticals Hemoglobinopathies Drugs Product Introduction, Application and Specification
Table Prolong Pharmaceuticals Hemoglobinopathies Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Prolong Pharmaceuticals Hemoglobinopathies Drugs Production Growth Rate (2014-2019)
Table Prolong Pharmaceuticals Hemoglobinopathies Drugs Production Market Share (2014-2019)
Figure Prolong Pharmaceuticals Hemoglobinopathies Drugs Revenue Market Share (2014-2019)
Table Prolong Pharmaceuticals Hemoglobinopathies Drugs Main Business and Markets Served
Table Celgene Corporation Hemoglobinopathies Drugs Production Sites and Area Served
Table HemaQuest Pharmaceuticals Hemoglobinopathies Drugs Production Sites and Area Served
Figure Global Hemoglobinopathies Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Hemoglobinopathies Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hemoglobinopathies Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Hemoglobinopathies Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Hemoglobinopathies Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hemoglobinopathies Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Hemoglobinopathies Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hemoglobinopathies Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Hemoglobinopathies Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hemoglobinopathies Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Hemoglobinopathies Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hemoglobinopathies Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Hemoglobinopathies Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hemoglobinopathies Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Hemoglobinopathies Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Hemoglobinopathies Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Hemoglobinopathies Drugs by Application (2019-2025)
Table Hemoglobinopathies Drugs Distributors List
Table Hemoglobinopathies Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…- 非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…
- 腎細胞がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport primary urine. RCC is the most common type of kidney cancer in adults, responsible for approximately 90–95% of cases.The drug is …
- セリアック病薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers. Scope of the Report: This report studies…
- ポンペ病治療薬のグローバル市場調査 2019年 The global Pompe Disease Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pompe Disease Drugs volume and value at global level, regional level and company level. From a global perspective, this…